Premium
Genetic Markers of Cisplatin‐Induced Hearing Loss in Children
Author(s) -
Carleton B C,
Ross C J,
Pussegoda K,
Bhavsar A P,
Visscher H,
Lee J W,
Brooks B,
Rassekh S R,
Dubé MP P,
Hayden M R
Publication year - 2014
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2014.92
Subject(s) - clinical pharmacology , cisplatin , hearing loss , medicine , audiology , psychology , pharmacology , chemotherapy
This journal recently published a Commentary by Ratain and colleagues at the University of Chicago that criticizes our work on cisplatin‐induced hearing loss in children. It is unfortunate that neither the authors nor the editors of Clinical Pharmacology & Therapeutics corresponded with us to provide an earlier opportunity to address these questions. Here we correct the authors' inaccuracies and provide additional analyses that further strengthen our published findings. Clinical Pharmacology & Therapeutics (2014); 96 3, 296–298. doi: 10.1038/clpt.2014.92